Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Regular smoking is not associated with increased thrombin generation in young adults.

Haidl H, Schlagenhauf A, Cimenti C, Schweintzger S, Grangl G, Leschnik B, Muntean W.

J Thromb Haemost. 2013 Jul;11(7):1433-5. doi: 10.1111/jth.12298. No abstract available.

2.

The myriad effects of cigarette smoke.

Nair S, Ghosh K.

J Thromb Haemost. 2013 Feb;11(2):387-8. doi: 10.1111/jth.12081. No abstract available.

3.

Interaction between blood type, smoking and factor V Leiden mutation and risk of venous thromboembolism: a Danish case-cohort study.

El-Galaly TC, Kristensen SR, Overvad K, Steffensen R, Tjønneland A, Severinsen MT.

J Thromb Haemost. 2012 Oct;10(10):2191-3. doi: 10.1111/j.1538-7836.2012.04772.x. No abstract available.

4.

Cigarette smoking and the risk of venous thromboembolism: the Tromsø Study.

Enga KF, Braekkan SK, Hansen-Krone IJ, le Cessie S, Rosendaal FR, Hansen JB.

J Thromb Haemost. 2012 Oct;10(10):2068-74. doi: 10.1111/j.1538-7836.2012.04880.x.

5.

Epidemiology of venous thromboembolism: the need for large (including prospective) studies and meta-analyses.

Lowe GD.

J Thromb Haemost. 2012 Oct;10(10):2186-8. doi: 10.1111/j.1538-7836.2012.04882.x. No abstract available.

6.

Etiology of venous thrombosis: the need for small original studies.

Rosendaal FR.

J Thromb Haemost. 2012 Oct;10(10):2189-90. doi: 10.1111/j.1538-7836.2012.04881.x. No abstract available.

7.

Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.

Chaireti R, Jennersjö C, Lindahl TL.

Thromb Res. 2009 Jun;124(2):178-84. doi: 10.1016/j.thromres.2008.12.033. Epub 2009 Feb 20.

PMID:
19232683
8.

Genetic susceptibility, smoking, obesity and risk of venous thromboembolism.

Severinsen MT, Overvad K, Johnsen SP, Dethlefsen C, Madsen PH, Tjønneland A, Kristensen SR.

Br J Haematol. 2010 Apr;149(2):273-9. doi: 10.1111/j.1365-2141.2010.08086.x. Epub 2010 Feb 8.

PMID:
20148880
9.

Risk for venous thromboembolism in patients with superficial venous thrombosis.

Bachmeyer C.

Ann Intern Med. 2010 Jul 6;153(1):62-3; author reply 63. doi: 10.7326/0003-4819-153-1-201007060-00024. No abstract available.

PMID:
20621913
10.

Quantification of hypercoagulable state after blunt trauma: microparticle and thrombin generation are increased relative to injury severity, while standard markers are not.

Park MS, Owen BA, Ballinger BA, Sarr MG, Schiller HJ, Zietlow SP, Jenkins DH, Ereth MH, Owen WG, Heit JA.

Surgery. 2012 Jun;151(6):831-6. doi: 10.1016/j.surg.2011.12.022. Epub 2012 Feb 7.

11.

Thrombotic risks of oral contraceptives.

Rott H.

Curr Opin Obstet Gynecol. 2012 Aug;24(4):235-40. doi: 10.1097/GCO.0b013e328355871d. Review.

PMID:
22729096
12.

Smoking and venous thromboembolism: a Danish follow-up study.

Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjønneland A, Overvad K.

J Thromb Haemost. 2009 Aug;7(8):1297-303. doi: 10.1111/j.1538-7836.2009.03490.x. Epub 2009 Jun 30.

13.

Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the Tromso study.

Brækkan SK, Hald EM, Mathiesen EB, Njølstad I, Wilsgaard T, Rosendaal FR, Hansen JB.

Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):487-91. doi: 10.1161/ATVBAHA.111.237545. Epub 2011 Nov 10.

14.

[Oral contraceptive pill and thrombotic risk: epidemiological studies].

Fruzzetti F, Perini D, Spirito N, Manca R.

Minerva Ginecol. 2012 Dec;64(6):539-49. Review. Italian.

PMID:
23232538
15.

CYP1A1, smoking and venous thromboembolism.

Zhu J, Zheng WJ, Kong FC, Zhang WJ, Wang HY, Wang C.

Thromb Haemost. 2010 Oct;104(4):702-8. doi: 10.1160/TH10-01-0078. Epub 2010 Jul 20.

PMID:
20664892
16.
17.

Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study.

Holst AG, Jensen G, Prescott E.

Circulation. 2010 May 4;121(17):1896-903. doi: 10.1161/CIRCULATIONAHA.109.921460. Epub 2010 Apr 19.

18.

Increased procoagulant function of microparticles in pediatric inflammatory bowel disease: role in increased thrombin generation.

Deutschmann A, Schlagenhauf A, Leschnik B, Hoffmann KM, Hauer A, Muntean W.

J Pediatr Gastroenterol Nutr. 2013 Apr;56(4):401-7. doi: 10.1097/MPG.0b013e31827daf72.

PMID:
23164759
19.

Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study.

Ay C, Dunkler D, Simanek R, Thaler J, Koder S, Marosi C, Zielinski C, Pabinger I.

J Clin Oncol. 2011 May 20;29(15):2099-103. doi: 10.1200/JCO.2010.32.8294. Epub 2011 Apr 4.

PMID:
21464402
20.

Assessing the use of venous thromboembolism risk assessment profiles in the trauma population: is it necessary?

Acuña DL, Berg GM, Harrison BL, Wray T, Dorsch D, Sook C.

Am Surg. 2011 Jun;77(6):783-9.

PMID:
21679651

Supplemental Content

Support Center